| Tertiles of serum sRAGE |  | ||
---|---|---|---|---|
Median, interquartile range (pg/mL) | Low (n = 238) | Middle (n =237) | High (n =237) | P for trendb |
 | (847.6, 710.0–950.0) | (1259.1, 1152.8–1377.2) | (1835.0, 1608.9–2107.8) |  |
MetS | Â | Â | Â | Â |
 Crude | 1.00 | 0.85 (0.57–1.27) | 0.47 (0.31–0.73) | <0.001 |
 Model 1c | 1.00 | 0.89 (0.59–1.35) | 0.45 (0.28–0.71) | 0.001 |
 Model 2d | 1.00 | 1.04 (0.67–1.61) | 0.58 (0.36–0.95) | 0.038 |
Central obesity | Â | Â | Â | Â |
 Crude | 1.00 | 0.88 (0.60–1.29) | 0.37 (0.24–0.57) | <0.001 |
 Model 1c | 1.00 | 0.86 (0.58–1.27) | 0.33 (0.21–0.52) | <0.001 |
 Model 2d | 1.00 | 0.96 (0.64–1.45) | 0.41 (0.25–0.66) | <0.001 |
 Model 3e | 1.00 | 0.99 (0.65–1.52) | 0.46 (0.28–0.75) | 0.003 |
Elevated BP | Â | Â | Â | Â |
 Crude | 1.00 | 0.55 (0.38–0.80) | 0.33 (0.22–0.48) | <0.001 |
 Model 1c | 1.00 | 0.61 (0.40–0.93) | 0.38 (0.25–0.57) | <0.001 |
 Model 2d | 1.00 | 0.66 (0.43–1.02) | 0.45 (0.29–0.70) | <0.001 |
 Model 3e | 1.00 | 0.65 (0.42–1.01) | 0.49 (0.31–0.77) | 0.002 |
Elevated FBG | Â | Â | Â | Â |
 Crude | 1.00 | 1.01 (0.69–1.48) | 0.70 (0.47–1.04) | 0.078 |
 Model 1c | 1.00 | 1.17 (0.78–1.75) | 0.89 (0.58–1.37) | 0.64 |
 Model 2d | 1.00 | 1.21 (0.81–1.84) | 0.97 (0.63–1.51) | 0.95 |
 Model 3e | 1.00 | 1.29 (0.85–1.96) | 1.20 (0.76–1.89) | 0.40 |
Elevated TG | Â | Â | Â | Â |
 Crude | 1.00 | 1.01 (0.69–1.47) | 0.68 (0.46–1.03) | 0.054 |
 Model 1c | 1.00 | 1.00 (0.68–1.48) | 0.62 (0.41–0.93) | 0.024 |
 Model 2d | 1.00 | 1.11 (0.74–1.65) | 0.75 (0.49–1.65) | 0.19 |
 Model 3e | 1.00 | 1.17 (0.77–1.77) | 0.85 (0.54–1.33) | 0.50 |
Reduced HDL-C | Â | Â | Â | Â |
 Crude | 1.00 | 0.91 (0.54–1.52) | 0.94 (0.56–1.57) | 0.81 |
 Model 1c | 1.00 | 0.77 (0.44–1.33) | 0.63 (0.36–1.11) | 0.11 |
 Model 2d | 1.00 | 0.88 (0.45–1.56) | 0.87 (0.46–1.56) | 0.65 |
 Model 3e | 1.00 | 0.85 (0.47–1.53) | 0.90 (0.48–1.68) | 0.74 |